Antibody Resource

Anti-mouse antibodies remain vital research tools. Biointron delivers reliable anti-mouse antibodies that support validation and consistent experimental results.

Isotype negative antibodies are essential controls. Biointron outlines their role in research, ensuring reliable data and validating experimental outcomes.

Innovative antibody formats like VHHs, scFvs, and ADCs expand therapeutic options. Biointron explores how these formats drive flexibility and efficacy.

Monoclonal antibodies are cornerstones of biotech. Biointron reviews their discovery, mechanisms, and applications in diagnostics and therapeutic innovation.

Antibodies are versatile research tools. Biointron highlights their applications in diagnostics, validation, and experimental discovery across biotechnology.

Effector functions drive antibody impact. Biointron reviews ADCC, CDC, and other mechanisms that enable antibodies to protect health and guide new therapies.

Genetic variations create antibody allotypes. Biointron highlights their implications for immunology, clinical studies, and therapeutic antibody development.

Antibody isotypes serve distinct immune roles. Biointron explores IgA, IgD, IgE, IgG, and IgM structures and functions in diagnostics, research, and therapy.

Antibody research has evolved dramatically. Biointron traces antibodies from their discovery to their modern roles in diagnostics, therapy, and drug development.

ADCs combine antibody targeting with potent drugs. Biointron outlines unique properties, advantages, and applications that make ADCs vital therapeutic tools.

Antibody diagnostics like ELISA and lateral flow assays are essential tools. Biointron showcases their role in reliable disease detection and rapid clinical decisions.

Antibody-mediated phagocytosis strengthens anti-cancer responses. Biointron explores how ADCP mechanisms support immunotherapy and enhance therapeutic outcomes.